Showing results (91-100 of 112) with videos related to

Sort By:
Pageof 12
Journal of the American College of Cardiology|October 19, 2019
Efficacy and Safety of Ticagrelor Monotherapy in Patients Undergoing Multivessel PCIKuniaki Takahashi, Patrick W Serruys, Ply Chichareon, et al.
Clinical Research in Cardiology : Official Journal of the German Cardiac Society|January 12, 2020
Impact of renal function on clinical outcomes after PCI in ACS and stable CAD patients treated with ticagrelor: a prespecified analysis of the GLOBAL LEADERS randomized clinical trialMariusz Tomaniak, Ply Chichareon, Dominika Klimczak-Tomaniak, et al.
Circulation. Cardiovascular Quality and Outcomes|August 9, 2020
Comparative Methodological Assessment of the Randomized GLOBAL LEADERS Trial Using Total Ischemic and Bleeding EventsHironori Hara, David van Klaveren, Kuniaki Takahashi, et al.
European Heart Journal|September 13, 2019
Uncertainties and challenges in surgical and transcatheter tricuspid valve therapy: a state-of-the-art expert reviewChun Chin Chang, Kevin M Veen, Rebecca T Hahn, et al.
European Heart Journal|May 14, 2020
Vulnerable plaques and patients: state-of-the-artMariusz Tomaniak, Yuki Katagiri, Rodrigo Modolo, et al.
Circulation. Cardiovascular Interventions|December 14, 2019
Impact of Fractional Flow Reserve Derived From Coronary Computed Tomography Angiography on Heart Team Treatment Decision-Making in Patients With Multivessel Coronary Artery Disease: Insights From the SYNTAX III REVOLUTION TrialDaniele Andreini, Rodrigo Modolo, Yuki Katagiri, et al.
International Journal of Cardiology|March 9, 2019
Predictive ability of ACEF and ACEF II score in patients undergoing percutaneous coronary intervention in the GLOBAL LEADERS studyPly Chichareon, Rodrigo Modolo, David van Klaveren, et al.
The American Journal of Cardiology|October 26, 2019
Ascertainment of Silent Myocardial Infarction in Patients Undergoing Percutaneous Coronary Intervention (from the GLOBAL LEADERS Trial)Chun Chin Chang, Ernest Spitzer, Ply Chichareon, et al.
European Heart Journal. Cardiovascular Pharmacotherapy|December 27, 2019
Impact of chronic obstructive pulmonary disease and dyspnoea on clinical outcomes in ticagrelor treated patients undergoing percutaneous coronary intervention in the randomized GLOBAL LEADERS trialMariusz Tomaniak, Ply Chichareon, Kuniaki Takahashi, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|December 18, 2019
Ticagrelor monotherapy beyond one month after PCI in ACS or stable CAD in elderly patients: a pre-specified analysis of the GLOBAL LEADERS trialMariusz Tomaniak, Ply Chichareon, Rodrigo Modolo, et al.
Pageof 12